about
A food-grade enzyme preparation with modest gluten detoxification propertiesMolecular and immunological characterization of gluten proteins isolated from oat cultivars that differ in toxicity for celiac diseaseThe molecular basis for oat intolerance in patients with celiac diseaseSpectrum of gluten-related disorders: consensus on new nomenclature and classificationCeliac disease: prevalence, diagnosis, pathogenesis and treatmentRecent advances in coeliac diseaseCeliac disease and non-celiac gluten sensitivityIdentification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprueCeliac and Non-Celiac Forms of Gluten Sensitivity: Shifting Paradigms of an Old DiseaseThe gluten-free diet: safety and nutritional qualityInterferon-γ activates transglutaminase 2 via a phosphatidylinositol-3-kinase-dependent pathway: implications for celiac sprue therapyDiversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity in coeliac diseaseIn vivo fluorescence imaging of exogenous enzyme activity in the gastrointestinal tractCeliac disease, inflammation and oxidative damage: a nutrigenetic approachActivation of extracellular transglutaminase 2 by thioredoxinIdentification of transglutaminase-mediated deamidation sites in a recombinant alpha-gliadin by advanced mass-spectrometric methodologiesConsumption of pure oats by individuals with celiac disease: a position statement by the Canadian Celiac AssociationProtein engineering of improved prolyl endopeptidases for celiac sprue therapyCeliac disease: pathophysiology, clinical manifestations, and associated autoimmune conditionsCross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac diseaseA role for tissue transglutaminase in alpha-gliadin peptide cytotoxicityIgA antibodies of coeliac disease patients recognise a dominant T cell epitope of A-gliadinOats to children with newly diagnosed coeliac disease: a randomised double blind studyHarnessing Aptamers to Overcome Challenges in Gluten DetectionGliadin-Specific T-Cells Mobilized in the Peripheral Blood of Coeliac Patients by Short Oral Gluten Challenge: Clinical ApplicationsThe Role of Gluten in Celiac Disease and Type 1 DiabetesMHC Class II Auto-Antigen Presentation is UnconventionalDietary gluten and the development of type 1 diabetesTherapeutic approaches for celiac diseaseNon-dietary methods in the treatment of celiac diseaseCeliac disease: quantity mattersThe diagnosis and treatment of celiac diseaseNovel therapeutic/integrative approaches for celiac disease and dermatitis herpetiformisCurrent and emerging therapy for celiac diseaseImmune development and intestinal microbiota in celiac diseaseGliadin Induces Neutrophil Migration via Engagement of the Formyl Peptide Receptor, FPR1Visualization of transepithelial passage of the immunogenic 33-residue peptide from alpha-2 gliadin in gluten-sensitive macaquesEngineering of Kuma030: A Gliadin Peptidase That Rapidly Degrades Immunogenic Gliadin Peptides in Gastric Conditions.T-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac diseaseAntibodies in celiac disease: implications beyond diagnostics.
P2860
Q21091194-428E1572-5D4C-4C5F-AA20-87872D43D3FEQ21133915-15401C36-D294-4BCA-8C4F-F581F7830A2DQ21144729-677CE281-0F77-437C-8413-4AA09D3FAC45Q21245301-DC885E01-4F2F-4054-AE96-3253A6FCA824Q22305490-D22EB41D-335A-41C6-AE02-F8B843D26388Q22306523-8D92893A-CA9D-43F7-8AB8-8BC4F66414C7Q22306535-B4903294-BC1D-4CA2-811B-83CB6A201AECQ24538575-EFAD9318-CF47-431C-9B1A-62624258FA84Q24564494-EED8EBE9-7BAC-4741-9E7B-6F513AB35968Q24610306-C907EB7D-A50E-439B-975D-AB1184BEE5BEQ24611233-7AA8E6D0-9016-4511-BD7A-A5AF050EBAD3Q24616555-0FEE41D9-C689-4FA7-BDF1-38053DFC5BA8Q24627253-2AC6E849-175E-4F3C-96C4-443D53FF9064Q24627269-8DF0FD96-D3E9-4E3A-8048-CCA4E42960E8Q24634746-EA4F56FF-0D6D-47BC-9201-3041273835E6Q24646948-0BBB1A66-4CA0-4912-8D01-5D4E67E04ADDQ24655324-BF2E189A-57E3-4F6D-830F-52A1E0524DE4Q24657645-2B9B8FBD-59FC-4713-8574-93B288B47CE0Q24658242-DF30AD10-D539-48EF-B159-75AD10AF9014Q24680243-24D3041C-088E-4604-8788-06A2E444C181Q24683342-44E62870-E96C-4E8B-9DB1-120F4E595995Q24685844-2A8F4C10-86ED-4605-BAB6-D79C7F98D79EQ24685888-E2F6F0FF-6AE0-4AED-A34B-222DD8C00AEBQ26750924-DA913D39-CE7C-4EB6-9622-D8D4912D175DQ26775020-DF3D62EF-8756-44CB-AAC3-8A2558F2BE0EQ26783642-70681E5F-1DBC-426D-B71C-26785154A24FQ26800138-0B05028C-B737-42CA-8404-0E9A4C0028F4Q26823584-B247CC20-8C47-4297-9749-DDAB0F3EF8B6Q26825413-FB7DFF78-5EE6-4EF5-B3E5-76AB1D7263EFQ26863359-E779F6FF-E004-441D-87DC-2DDB174CEC6EQ26865115-A6FFC1A4-EB6F-41DC-868A-BD4EA22D88E2Q26865802-34661D5B-1514-4E4A-AE2A-5584AD73518FQ27010008-E45048DB-7A3E-4756-A633-28B807047271Q27014843-C67D4013-F3C9-4212-A16C-D994C968217AQ27026098-E11E980A-FA5C-48F4-9175-A9D644F64EDCQ27317169-E130AFF5-CABD-4CB7-B596-B52E1A50407DQ27331370-2FB03EC4-07A4-4860-8505-C74010D7EFBBQ27336477-CC810F59-3CEF-42AF-BD91-4B64B0306ECBQ27690116-478ECA75-835D-42B1-AC4C-7A64F8BAF602Q27693707-95984CDB-D0DB-486B-9952-74294DACFFE8
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Structural basis for gluten intolerance in celiac sprue
@ast
Structural basis for gluten intolerance in celiac sprue
@en
type
label
Structural basis for gluten intolerance in celiac sprue
@ast
Structural basis for gluten intolerance in celiac sprue
@en
prefLabel
Structural basis for gluten intolerance in celiac sprue
@ast
Structural basis for gluten intolerance in celiac sprue
@en
P2093
P3181
P356
P1433
P1476
Structural basis for gluten intolerance in celiac sprue
@en
P2093
Chaitan Khosla
Felix Hausch
Ferda Filiz
Gary M Gray
Isabelle Parrot
Ludvig M Sollid
Øyvind Molberg
P304
P3181
P356
10.1126/SCIENCE.1074129
P407
P50
P577
2002-09-01T00:00:00Z